Christopher S. Boerner - Net Worth and Insider Trading

Christopher S. Boerner Net Worth

The estimated net worth of Christopher S. Boerner is at least $22 Million dollars as of 2025-07-23. Christopher S. Boerner is the Executive Vice President, Comm of Seagen Inc and owns about 72,358 shares of Seagen Inc (SGEN) stock worth over $17 Million. Christopher S. Boerner is also the CEO of Bristol-Myers Squibb Co and owns about 104,626 shares of Bristol-Myers Squibb Co (BMY) stock worth over $5 Million. Details can be seen in Christopher S. Boerner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher S. Boerner has not made any transactions after 2025-02-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Christopher S. Boerner

To

Christopher S. Boerner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher S. Boerner owns 3 companies in total, including Bristol-Myers Squibb Co (BMY) , Seagen Inc (SGEN) , and Achaogen Inc (AKAOQ) .

Click here to see the complete history of Christopher S. Boerner’s form 4 insider trades.

Insider Ownership Summary of Christopher S. Boerner

Ticker Company Transaction Date Type of Owner
BMY Bristol-Myers Squibb Co 2025-02-20 EVP & Chief Commercial Officer
SGEN Seagen Inc 2014-08-24 SVP & Commercial
AKAOQ Achaogen Inc 2014-03-27 director

Christopher S. Boerner Latest Holdings Summary

Christopher S. Boerner currently owns a total of 2 stocks. Among these stocks, Christopher S. Boerner owns 72,358 shares of Seagen Inc (SGEN) as of August 24, 2014, with a value of $17 Million and a weighting of 76.71%. Christopher S. Boerner also owns 104,626 shares of Bristol-Myers Squibb Co (BMY) as of February 20, 2025, with a value of $5 Million and a weighting of 23.29%.

Latest Holdings of Christopher S. Boerner

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGEN Seagen Inc 2014-08-24 72,358 228.74 16,551,169
BMY Bristol-Myers Squibb Co 2025-02-20 104,626 48.02 5,024,141

Holding Weightings of Christopher S. Boerner


Christopher S. Boerner Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher S. Boerner has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the sale of 1,248 shares on August 24, 2014, which brought Christopher S. Boerner around $54,350.

According to the SEC Form 4 filings, Christopher S. Boerner has made a total of 3 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Bristol-Myers Squibb Co is the acquisition of 2,000 shares on February 20, 2025, which cost Christopher S. Boerner around $110,100.

Insider Trading History of Christopher S. Boerner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher S. Boerner Trading Performance

GuruFocus tracks the stock performance after each of Christopher S. Boerner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher S. Boerner is -2.31%. GuruFocus also compares Christopher S. Boerner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher S. Boerner within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher S. Boerner's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher S. Boerner

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.66 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.51 LIMIT LIMIT LIMIT LIMIT LIMIT

Christopher S. Boerner Ownership Network

Ownership Network List of Christopher S. Boerner

No Data

Ownership Network Relation of Christopher S. Boerner

Insider Network Chart


Christopher S. Boerner Owned Company Details

What does Bristol-Myers Squibb Co do?

Who are the key executives at Bristol-Myers Squibb Co?

Christopher S. Boerner is the EVP & Chief Commercial Officer of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include Chief Medical Offr. & Drug Dev. Samit Hirawat , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .

Bristol-Myers Squibb Co (BMY) Insider Trades Summary

Over the past 18 months, Christopher S. Boerner made 1 insider transaction in Bristol-Myers Squibb Co (BMY) with a net purchase of 2,000. Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 7,903 shares made by Samit Hirawat , a net sale of 700 shares made by , and a net sale of 97 shares made by Benjamin Hickey .

In summary, during the past 3 months, insiders sold 97 shares of Bristol-Myers Squibb Co (BMY) in total and bought 4,250 shares, with a net purchase of 4,153 shares. During the past 18 months, 797 shares of Bristol-Myers Squibb Co (BMY) were sold and 9,903 shares were bought by its insiders, resulting in a net purchase of 9,106 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bristol-Myers Squibb Co Insider Transactions

No Available Data

Christopher S. Boerner Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher S. Boerner. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher S. Boerner's mailing address is: Bothell Wa 98021.